Cargando…

Assessment of retrospective collection of EQ-5D-5L in a US COVID-19 population

BACKGROUND: It is imperative to evaluate health related quality of life (HRQoL) pre-COVID-19, but there is currently no evidence of the retrospective application of the EuroQol 5-Dimension, 5 level version (EQ-5D-5L) for COVID-19 studies. METHODS: Symptomatic patients with SARS-CoV-2 at CVS Health U...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xiaowu, Di Fusco, Manuela, Puzniak, Laura, Coetzer, Henriette, Zamparo, Joann M., Tabak, Ying P., Cappelleri, Joseph C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486034/ https://www.ncbi.nlm.nih.gov/pubmed/37679771 http://dx.doi.org/10.1186/s12955-023-02187-x

Ejemplares similares

Impact of COVID-19 and effects of BNT162b2 on patient-reported outcomes: quality of life, symptoms, and work productivity among US adult outpatients
por: Di Fusco, Manuela, et al.
Publicado: (2022)

Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron
por: Di Fusco, Manuela, et al.
Publicado: (2023)

Impact of Bivalent BA.4/5 BNT162b2 COVID-19 Vaccine on Acute Symptoms, Quality of Life, Work Productivity and Activity Levels among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy
por: Di Fusco, Manuela, et al.
Publicado: (2023)

Validity of EQ-5D-5L in stroke
por: Golicki, Dominik, et al.
Publicado: (2014)

Impact of COVID-19 Infection on Health-Related Quality of Life, Work Productivity and Activity Impairment by Symptom-Based Long COVID Status and Age in the US
por: Di Fusco, Manuela, et al.
Publicado: (2023)

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
por: Golicki, Dominik, et al.
Publicado: (2014)

EQ-5D-5L measurement properties are superior to EQ-5D-3L across the continuum of health using US value sets
por: Jiang, Ruixuan, et al.
Publicado: (2022)

Population norms for the EQ-5D-3L and EQ-5D-5L in Romania
por: Olariu, Elena, et al.
Publicado: (2023)

Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults
por: Ferreira, Lara N., et al.
Publicado: (2016)

Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets
por: Mulhern, Brendan, et al.
Publicado: (2018)

Head-to-Head Comparison of EQ‐5D‐3L and EQ‐5D‐5L Health Values
por: Selivanova, Anna, et al.
Publicado: (2018)

Comparing the performance of the EQ-5D-3 L and the EQ-5D-5 L in an elderly Chinese population
por: You, Ruxu, et al.
Publicado: (2020)

Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients
por: Pattanaphesaj, Juntana, et al.
Publicado: (2015)

Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets
por: Mulhern, Brendan, et al.
Publicado: (2018)

The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa
por: Bató, Alex, et al.
Publicado: (2021)

Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran
por: Moradi, Nasrin, et al.
Publicado: (2022)

Valuation of the EQ-5D-5L in Taiwan
por: Lin, Hsiang-Wen, et al.
Publicado: (2018)

QALYs for COVID-19: A Comparison of US EQ-5D-5L Value Sets
por: Poteet, Stephen, et al.
Publicado: (2021)

BNT162b2 Against COVID-19-Associated Emergency Department and Urgent Care Visits Among Children 5–11 Years of Age: A Test Negative Design
por: Tartof, Sara Y, et al.
Publicado: (2023)

Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients
por: Fitriana, Titi Sahidah, et al.
Publicado: (2021)

Comparison of the EQ-5D-Y-5L, EQ-5D-Y-3L and PedsQL in children and adolescents
por: Verstraete, Janine, et al.
Publicado: (2022)

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
por: Herdman, M., et al.
Publicado: (2011)

COVID-19 QALY values differ between US EQ-5D-5L value sets
Publicado: (2021)

A US Population Health Survey on the Impact of COVID-19 Using the EQ-5D-5L
por: Hay, Joel W., et al.
Publicado: (2021)

Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys
por: Martí-Pastor, Marc, et al.
Publicado: (2018)

Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis
por: Koszorú, Kamilla, et al.
Publicado: (2022)

EQ-5D-5L Polish population norms
por: Golicki, Dominik, et al.
Publicado: (2015)

German Value Set for the EQ-5D-5L
por: Ludwig, Kristina, et al.
Publicado: (2018)

The Indonesian EQ-5D-5L Value Set
por: Purba, Fredrick Dermawan, et al.
Publicado: (2017)

EQ-5D-5L Slovenian population norms
por: Prevolnik Rupel, Valentina, et al.
Publicado: (2020)

An EQ-5D-5L Value Set for Vietnam
por: Mai, Vu Quynh, et al.
Publicado: (2020)

The EQ-5D-5L Valuation Study in Egypt
por: Al Shabasy, Sahar, et al.
Publicado: (2021)

An EQ-5D-5L Value Set for Belgium
por: Bouckaert, Nicolas, et al.
Publicado: (2022)

EQ-5D-5L Population Norms for Italy
por: Meregaglia, Michela, et al.
Publicado: (2022)

EQ-5D-5L Portuguese population norms
por: Ferreira, Pedro L., et al.
Publicado: (2023)

EQ-5D-5L Value Set for Slovenia
por: Prevolnik Rupel, Valentina, et al.
Publicado: (2023)

EQ-5D-Y-5L: developing a revised EQ-5D-Y with increased response categories
por: Kreimeier, Simone, et al.
Publicado: (2019)

Developing the Chinese version of the new 5-level EQ-5D descriptive system: the response scaling approach
por: Luo, Nan, et al.
Publicado: (2012)

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
por: Shiroiwa, Takeru, et al.
Publicado: (2015)

How do EQ-5D-3L and EQ-5D-5L compare in a Swedish total hip replacement population?
por: Eneqvist, Ted, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_inpe1lbed5eigiok6h93du23or